PRICKLE4 and neoplasm: BLI results (Figure 5K,L) from these GC02‐IDHmut xenograft tumors on day 28 showed that Prickle4 knockdown did not affect tumor growth (Figure 5K,L), nor did it affect the survival of mice (Figure 5M) without veliparib treatment.